Lecuru F, Guilbaud N, Agostini A, Augereau C, Vilde F, Taurelle R
Service de Chirurgie Gynecologique, Hôpital European Georges Pompidou, 20 rue Leblanc, 75015 Paris, France.
Surg Endosc. 2001 Nov;15(11):1346-52. doi: 10.1007/s004640000073. Epub 2001 Aug 16.
Experimental laparoscopic trials require relevant models of ovarian carcinomatosis.
Female nude rats were inoculated intraperitoneally either with the IGR-OV1 or the NIH:OVCAR-3 human adenocarcinoma cell lines. Serial clinical checks and sacrifices were used to evaluate the rates of tumor take, survival, and patterns of tumor spread. Finally, laparoscopies with various pneumoperitoneum pressures were performed to verify the "surgical" relevancy of out models. The learning curve was measured.
The best results were obtained when twenty-seven 106 IGR-OV1 cells and thirty-six 106 NIH:OVCAR-3 cells were injected in 28-day-old rats. The IGR-OV1 model provided a mean survival of 17.8 days (range, 13-22 days), with a high take rate (94%). The NIH:OVCAR-3 model resulted in a longer mean survival (59 days; range, 49-77) and also a high take rate (83%). The two models differed in their patterns of tumor spread: solid bulky omental metastasis having a diffuse microscopic peritoneal carcinomatosis with the IGR-OV1 line (the weight of the omental cake correlated significantly with the stage of development) and diffuse macroscopic peritoneal carcinomatosis having no large solid tumor, but visceral and paraaortic metastases, with the NIH:OVCAR-3 line. In both models, CA125 was high. Anesthesia could be performed and repeated in healthy and tumor-bearing rats. Laparoscopy was feasible, with pneumoperitoneum pressures as high as 8 mmHg lasting 1 h. Laparoscopy provided a reliable evaluation of the tumor spread into the peritoneal cavity. The plateau of the learning curve was soon obtained for take rate and survival after laparoscopy.
We report two new human ovarian carcinoma xenografts in nude rats suitable for laparoscopy. The IGR-OV1 model mimics an advanced stage of the disease, and the NIH:OVCAR-3 model presents an earlier stage. These two models appear useful for experiments involving laparoscopy.
实验性腹腔镜试验需要相关的卵巢癌种植转移模型。
将IGR-OV1或NIH:OVCAR-3人腺癌细胞系腹腔内接种于雌性裸鼠。通过系列临床检查和处死动物来评估肿瘤接种成功率、生存率及肿瘤播散模式。最后,采用不同气腹压力进行腹腔镜检查,以验证我们模型的“手术”相关性,并测定学习曲线。
将27×10⁶个IGR-OV1细胞和36×10⁶个NIH:OVCAR-3细胞注入28日龄大鼠时取得了最佳结果。IGR-OV1模型的平均生存期为17.8天(范围13 - 22天),接种成功率高(94%)。NIH:OVCAR-3模型的平均生存期更长(59天;范围49 - 77天),接种成功率也高(83%)。两种模型的肿瘤播散模式不同:IGR-OV1细胞系表现为实性、大块状网膜转移,伴有弥漫性微小腹膜癌转移(网膜饼重量与疾病发展阶段显著相关);NIH:OVCAR-3细胞系表现为弥漫性肉眼可见的腹膜癌转移,无大的实性肿瘤,但有内脏和腹主动脉旁转移。在两种模型中,CA125均升高。在健康和荷瘤大鼠中均可进行并重复麻醉。腹腔镜检查可行,气腹压力高达8 mmHg可持续1小时。腹腔镜检查能可靠地评估肿瘤向腹腔内的播散情况。腹腔镜检查后,接种成功率和生存率的学习曲线很快达到平稳期。
我们报告了两种适用于腹腔镜检查的裸鼠人卵巢癌异种移植新模型。IGR-OV1模型模拟疾病晚期,NIH:OVCAR-3模型呈现疾病早期。这两种模型似乎对涉及腹腔镜检查的实验有用。